Investor Relations

Conversion Right Extended on OPKO 3.0% Convertible Senior Notes more »

OPKO Health to Present at the Ladenburg Thalmann 2015 Healthcare Conference more »

OPKO Health Announces Global License Agreement for the Discovery of Novel Antimicrobials more »

OPKO Licensee TESARO Receives FDA Approval for VARUBI™ (rolapitant) more »

Investor Relations

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put OPKO Health, Inc.'s financial performance into perspective.

Former shareholders of Bio-Reference Laboratories, Inc. that have questions related to the exchange of BRLI shares to OPK shares, please contact our exchange agent, American Stock Transfer & Trust Company, LLC, toll free at (877) 248-6417 or (718) 921-8317.

  • Events

  • Stock Information

Ticker OPK Exchange NYSE
Last Price 8.70 Change 0.18 down
Open 8.95 Previous Close 8.88
Day High 9.08 Day Low 8.40
52-Week High 19.20 52-Week Low 8.02
Quotes delayed at least 20 minutes. Information provided by eSignal.